We are live on ! Find out more
ARVN icon

Arvinas

199 hedge funds and large institutions have $3.69B invested in Arvinas in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 81 increasing their positions, 60 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

453% more call options, than puts

Call options by funds: $27.4M | Put options by funds: $4.96M

35% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 60

22% more funds holding in top 10

Funds holding in top 10: 911 (+2)

1% more capital invested

Capital invested by funds: $3.64B → $3.69B (+$51.2M)

0.95% more ownership

Funds ownership: 84.07%85.03% (+0.95%)

9% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 35

2% less funds holding

Funds holding: 204199 (-5)

Holders
199
Holders Change
-5
Holders Change %
-2.45%
% of All Funds
3.06%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.17%
New
32
Increased
81
Reduced
60
Closed
35
Calls
$27.4M
Puts
$4.96M
Net Calls
+$22.4M
Net Calls Change
+$18.4M
Name Holding Trade Value Shares
Change
Change in
Stake
EA
26
Emerald Advisers
Pennsylvania
$26.1M +$2.74M +33,634 +12%
Barclays
27
Barclays
United Kingdom
$25.5M +$702K +8,632 +3%
EMFAT
28
Emerald Mutual Fund Advisers Trust
Pennsylvania
$24.9M +$671K +8,240 +3%
Nomura Holdings
29
Nomura Holdings
Japan
$24.2M +$938K +11,525 +4%
NI
30
Nextech Invest
Switzerland
$23.6M +$23.4M +287,251 New
UBS Group
31
UBS Group
Switzerland
$23.5M +$11.7M +143,289 +100%
EAM
32
Eagle Asset Management
Florida
$23.4M -$313K -3,851 -1%
Goldman Sachs
33
Goldman Sachs
New York
$23M -$7.49M -92,007 -25%
N
34
Nuveen
North Carolina
$22.5M -$6.61M -81,279 -23%
PBA
35
Paradigm Biocapital Advisors
New York
$22.1M +$21.9M +268,519 New
Morgan Stanley
36
Morgan Stanley
New York
$20.4M -$40.4M -496,183 -67%
Jennison Associates
37
Jennison Associates
New York
$19.7M +$6.41M +78,780 +49%
ABG
38
Ally Bridge Group
New York
$18.9M +$1.63M +20,000 +10%
CCP
39
Clough Capital Partners
Massachusetts
$18.8M +$5.15M +63,300 +38%
Bank of America
40
Bank of America
North Carolina
$18.8M +$2.74M +33,642 +17%
Two Sigma Advisers
41
Two Sigma Advisers
New York
$17.8M -$9.7M -119,200 -35%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$16.4M +$172K +2,113 +1%
Deutsche Bank
43
Deutsche Bank
Germany
$15.8M -$6.16M -75,699 -28%
OCA
44
Octagon Capital Advisors
New York
$14.7M +$814K +10,000 +6%
SAM
45
Sectoral Asset Management
Quebec, Canada
$14.6M -$10.6M -130,179 -42%
FM
46
Frazier Management
Washington
$13.5M +$13.3M +163,763 New
Millennium Management
47
Millennium Management
New York
$13M +$7.16M +88,044 +125%
Renaissance Technologies
48
Renaissance Technologies
New York
$11.2M +$4.38M +53,800 +65%
Alyeska Investment Group
49
Alyeska Investment Group
Illinois
$11.2M +$7.03M +86,331 +173%
EC
50
EcoR1 Capital
California
$10.7M +$10.6M +130,300 New

ARVN Hedge Fund Activity: Q4 2021 in Review

199 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Arvinas (ARVN) for Q4 2021, worth a combined $3.69B — up 1.4% from $3.64B a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of ARVN and 32 opened new positions — a net loss of 3 holders — while 60 trimmed existing stakes and 81 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $28.8M. The largest seller was Morgan Stanley, cutting an estimated $40.4M.

  • 199 institutional investors held Arvinas (ARVN) as of Q4 2021, down from 204 in Q3 2021.
  • Funds reported $3.69B of Arvinas stock for Q4 2021, up 1.4% quarter-over-quarter.
  • 32 funds opened new Arvinas positions in Q4 2021 and 35 closed out, a net change of -3 holders.
  • The largest Arvinas buyer in Q4 2021 was T. Rowe Price Associates, an estimated $28.8M added.
  • The largest Arvinas seller in Q4 2021 was Morgan Stanley, an estimated $40.4M sold.

Based on aggregated 13F filings for Q4 2021.